Managing cancer patients during the COVID-19 pandemic poses a variety of challenges for oncologists, including access to care, timing of treatments, resource availability and risk reduction. Cleveland Clinic Cancer Center oncologist Halle Moore, MD, offers guidance and insights.
Breast cancer patients’ use of certain dietary supplements before and during chemotherapy is linked to an increased risk of disease recurrence and death, a recent study involving Cleveland Clinic researchers has found.
As the new a co-chair of the survivorship committee of SWOG, a National Cancer Institute-supported network of cancer researchers, Dr. Moore will prioritize needs identified by cancer survivors.
Five-year follow-up data from the Prevention of Early Menopause Study shows use of goserelin, a gonadotropin hormone-releasing hor-mone agonist, along with standard chemotherapy, helps preserve fertility in women with breast cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Breast cancer survivors treated with chemotherapy were much more likely to experience long-term symptoms than those who did not receive chemotherapy, a Cleveland Clinic analysis finds.
Although uncommon in younger women, breast cancer poses unique medical and lifestyle challenges for this group. Cleveland Clinic has begun a Young Women’s Breast Cancer Clinic to coordinate care and address specific needs of patients younger than 50.
A new study in the New England Journal of Medicine suggests that ovarian failure — a major concern for women undergoing chemotherapy treatment for breast cancer — may be preventable in some patients by including goserelin with standard chemotherapy.